Maine, Rhode Island, and Vermont were the only 3 states to not report any pregnancy-associated firearm-related deaths from ...

Allen, ​​associate director of education and training at Camden Coalition, dives into the foundational skills in complex care that can enhance provider education and facilitate trusting ...

In an interview, Debra Patt, MD, PhD, MBA, FASCO, discusses the priorities of the Community Oncology Alliance as she starts ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Significant increases in breast cancer incidence were found among Hispanic, American Indian or Alaska Native, and Asian or ...

Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal ...

In an interview with The American Journal of Managed Care, Michael A. Bernstein, MD, stressed the need for effective ...

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...

Michael A. Bernstein, MD, Stamford Health, address common misconceptions about tuberculosis amid the outbreak in Kansas City, Kansas.

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid ...